We demonstrated that galectin-2 mRNA expression is increased in both monocytes and macrophages of coronary artery disease (CAD) patients with a low arteriogenic response and that galectin-2 impairs arteriogenesis in vivo in a murine model [11]. The gene discussed is LGALS2; the disease is coronary artery disorder.